Onyx Liquid Embolic Systems - Prosthesis, internal, embolization, intravascular

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Commercializzato da:

Medtronic Australasia Pty Ltd

Classe:

Class III

Prodotto da:

Micro Therapeutics Inc DBA ev3 Neurovascular 9775 Toledo Way, Irvine, CA, 92618 United States Of America

Area terapeutica:

35449 - Prosthesis, internal, embolization, intravascular

Indicazioni terapeutiche:

Liquid Onyx is delivered through a DMSO primed microcatheter placed within a feeding pedicle of an AVM or an aneurysm. The DMSO priming volume separates Onyx from blood, saline or contrast media within the cathteter lumen that may cause early precipitation and catheter occlusion. Onyx material is injected at a slow rate. Solidification of the material begins immediately upon injection, beginning as a "skin" on the outside of the mass./ Total solidification occurs within minutes. Embolization of intracranial aneurysms and lesions in the peripheral and neurovasculature including arteriovenous malformations and hypervascular tumours.

Stato dell'autorizzazione:

A

Data dell'autorizzazione:

2008-04-23